![Prevalence of fatty liver and advanced fibrosis by ultrasonography and FibroScan in a general population random sample - Nagaoki - 2022 - Hepatology Research - Wiley Online Library Prevalence of fatty liver and advanced fibrosis by ultrasonography and FibroScan in a general population random sample - Nagaoki - 2022 - Hepatology Research - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/8046a3d8-0826-4836-b9c0-176a65022080/hepr13821-fig-0002-m.png)
Prevalence of fatty liver and advanced fibrosis by ultrasonography and FibroScan in a general population random sample - Nagaoki - 2022 - Hepatology Research - Wiley Online Library
![Changes in hepatic steatosis (CAP) and fibrosis (LSM) by fibroscan post... | Download Scientific Diagram Changes in hepatic steatosis (CAP) and fibrosis (LSM) by fibroscan post... | Download Scientific Diagram](https://www.researchgate.net/publication/353070137/figure/fig1/AS:1043170632679444@1625722668529/Changes-in-hepatic-steatosis-CAP-and-fibrosis-LSM-by-fibroscan-post-surgery.png)
Changes in hepatic steatosis (CAP) and fibrosis (LSM) by fibroscan post... | Download Scientific Diagram
![Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12933-021-01388-2/MediaObjects/12933_2021_1388_Fig1_HTML.png)
Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study
![Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease - ScienceDirect Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0016508519301052-fx1.jpg)
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease - ScienceDirect
Transient Elastography-Based Liver Profiles in a Hospital-Based Pediatric Population in Japan | PLOS ONE
![Improvement in liver stiffness measurement for diagnosis of liver fibrosis in patients with concurrent chronic hepatitis B and nonalcoholic fatty liver disease - Nan Xu, Qinxiu Xie, Jiang Li, Yufeng Gao, Xu Improvement in liver stiffness measurement for diagnosis of liver fibrosis in patients with concurrent chronic hepatitis B and nonalcoholic fatty liver disease - Nan Xu, Qinxiu Xie, Jiang Li, Yufeng Gao, Xu](https://journals.sagepub.com/cms/10.1177/0300060520903667/asset/images/large/10.1177_0300060520903667-fig4.jpeg)
Improvement in liver stiffness measurement for diagnosis of liver fibrosis in patients with concurrent chronic hepatitis B and nonalcoholic fatty liver disease - Nan Xu, Qinxiu Xie, Jiang Li, Yufeng Gao, Xu
![Table 1 from The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. | Semantic Scholar Table 1 from The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/eb5b484e12cb14cd27afc429c89250458a83eef3/4-Table1-1.png)
Table 1 from The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. | Semantic Scholar
![Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine](https://www.thelancet.com/cms/attachment/49e98917-4058-4b9d-a18b-1d4d8f67ab34/gr2_lrg.jpg)
Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine
![Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter - ScienceDirect Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827817320147-fx1.jpg)